137.00
+0.81(+0.59%)
Currency In USD
| Previous Close | 136.19 |
| Open | 137.03 |
| Day High | 140.64 |
| Day Low | 136.4 |
| 52-Week High | 140.64 |
| 52-Week Low | 55.92 |
| Volume | 458,181 |
| Average Volume | 473,883 |
| Market Cap | 4.37B |
| PE | -43.63 |
| EPS | -3.14 |
| Moving Average 50 Days | 106.24 |
| Moving Average 200 Days | 89.52 |
| Change | 0.81 |
If you invested $1000 in iRhythm Technologies, Inc. (IRTC) since IPO date, it would be worth $5,259.12 as of May 09, 2025 at a share price of $137. Whereas If you bought $1000 worth of iRhythm Technologies, Inc. (IRTC) shares 5 years ago, it would be worth $1,045.56 as of May 09, 2025 at a share price of $137.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
GlobeNewswire Inc.
May 01, 2025 8:10 PM GMT
iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
GlobeNewswire Inc.
Apr 29, 2025 10:05 PM GMT
SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be p
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
GlobeNewswire Inc.
Apr 28, 2025 12:05 PM GMT
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.Latest data showed Zio LTCM was associated with higher diagnostic yield